David Stenehjem, PharmD
Research Assistant Profession
University of Utah, Department of Pharmacotherapy/ University of Utah Hospitals & Clinics, Huntsman Cancer Institute
Department of Pharmacotherapy and Program in Personalized Health Care/ Huntsman Cancer Institute
421 Wakara Way
suite 208
Salt Lake City,
UT
USA
84102
Papers:
CHRONIC MYELOID LEUKEMIA TREATMENT: STARTING WITH A HIGHLY POTENT TYROSINE KINASE INHIBITOR AND EARLY SWITCHING TO IMATINIB?